Central Enterprises More Than 2 Households Production Sub Enterprises Recovery Rate Has Exceeded 80%

At the news conference of the joint defense and joint control mechanism of the State Council held in February 18th, Ren Hongbin, deputy director of the SASAC, said: "the impact of the epidemic is phased and temporary. The SASAC's business objectives and reform tasks will not change at the beginning of this year. The SASAC and the central enterprises will take the initiative to relax their targets and take various measures to make every effort to accomplish the objectives and tasks of the year.

The Shanghai Securities Journal reporter noted that the A epidemic was frequently seen in the anti epidemic queue composed of central enterprises and subsidiaries. At the press conference, the contributions made by several A share companies such as China International Group, Su Mei Da, China Medical Company, and so on, for the fight against the epidemic were highlighted.

Go all out to accomplish the annual targets and tasks.

Ren Hongbin, deputy director of the SASAC, said at the meeting that the epidemic had a real impact on the production and operation of the central enterprises, such as aviation, tourism and other industries. However, we believe that the impact of the epidemic is phased and temporary. The impact of the epidemic will not change the fundamentals of China's long-term economic development. It is believed that with the gradual easing and elimination of the epidemic, the demand of these industries will rebound and return to normal gradually.

According to his introduction, at present, the central enterprises have more than 2 thousand production sub enterprises, and the recovery rate exceeds 80%, and oil and petrochemical, communications, power grid, electric power, transportation and other industries have more than 95% operating rate, and some have reached 100%. For example, the State Grid has fully rebuilt a number of major construction projects. The total construction scale of these projects exceeds 70 billion yuan, which can drive the upstream and downstream supporting industries to better resume production and resume production.

Ren Hongbin also said that the SASAC and the central enterprises will firmly grasp the goal, do not relax, ensure that the tasks remain unchanged and the pressure will not be reduced, and go all out to accomplish all the objectives and tasks of the year, so as to provide strong support for the smooth operation of the national economy.

Specifically, the SASAC and the central enterprises will take the following measures: first, actively and orderly, take the lead in the resumption of work, and make every effort to maintain stable operation of production and operation. The two is to strengthen the situation and analyze the situation of the industries and upstream and downstream industries of the central enterprises, strengthen the prediction and early warning, and formulate Countermeasures in time. Three, we must firmly establish the idea of "over tight days", intensify efforts to reduce costs, improve quality and increase efficiency, and work hard to offset losses caused by the epidemic. The four is to guide enterprises to make good use of the financial, fiscal and tax support policies that the state has to cope with the outbreak of the epidemic. We should grasp the opportunities that the post market epidemic and the resumption of market growth may bring after the epidemic situation, and do a good job in structural optimization and stable and stable production.

Push forward the production of medical materials

Ren Hongbin said that before the outbreak, the central enterprises basically did not have any layout on medical protective clothing and medical masks. After the outbreak of the epidemic, the central enterprises quickly switched production and expanded production, and promoted the production of medical materials. At present, xinjihua group produces 45 thousand sets of medical protective clothing everyday, and the national machine group, Sinopec and ordnance industry produce 1 million 300 thousand medical masks daily. Central enterprises are also stepping up the development of key equipment such as masks, layering machines and so on. They will also achieve mass production in the near future.

Ren Hongbin further indicated that the new China Group (Group) shares were rapidly transferred to produce equipment, trained employees and put them into production of protective clothing in wartime conditions after being issued instructions for production of protective clothing. The company's 3502 factory, located in Shijiazhuang, Hebei, has formed 45 thousand sets of daily medical protective clothing supply capability, which is more than 1/3 of the total production of medical protective clothing in China.

While accelerating the production of medical materials, central enterprises have also intensified their efforts in medical research and development. Zhao Shitang, Deputy Secretary General of the SASAC and spokesman, said that at present, the national drug group, Huarun group and general technology group are making great efforts to promote the scientific research of new crown pneumonia effective drugs, and have made some progress. For example, the Chinese biological group of the National Pharmaceutical Group has pioneered the development of a new type of coronavirus nucleic acid molecular detection kit, with a production capacity of 200 thousand people per day.

Vaccine research and development is also advancing in Wuhan, Beijing and other places. At present, the research and development of inactivated vaccine is being carried out by virus culture, and the research and development of recombinant genetic engineering vaccine has completed the synthesis of gene sequences, and other related work is also pressing ahead with the process.

Central enterprises are also accelerating the production reserve for the anti epidemic drug "chloroquine phosphate". General technology group can produce pharmaceutical products before the end of February. Huarun group is increasing its reserves on the basis of the existing chloroquine related products inventory of 325 thousand boxes. "The Chinese medicine of general technology group is now working hard to resume the production of chloroquine phosphate." Zhao Shitang said.

We will help small and medium-sized enterprises to overcome difficulties.

In the process of fighting the epidemic, relevant departments of the state have issued a series of fiscal and taxation policies, such as low interest loan policy, which will help further reduce the cost of production and operation and financing of enterprises, and increase the supply of anti epidemic materials and medical products.

Regarding this, Xia Qingfeng, director of the Propaganda Bureau of the State Council and the spokesman of the State Council, emphasized that low interest loans and other fiscal and financial policies are alike for all kinds of enterprises, and there is no special policy for state-owned enterprises. Epidemic prevention and control is in the critical period of tackling difficulties. The state owned enterprises meeting the policy requirements will apply for relevant support through open channels in accordance with the regulations, without special treatment.

"In the process of epidemic prevention, the land is divided into North and south, and enterprises are not separated from ownership. Everyone is in the same boat." Xia Qingfeng said, "in the face of the epidemic, SMEs are more vulnerable, supporting SMEs is taken for granted. The central enterprises will actively respond to the lead in the industrial chain cooperation."

In addition, the central enterprises will also properly handle legal disputes with SMEs. For the delayed delivery and delayed payment of small and medium enterprises caused by the epidemic, the SASAC will guide the central enterprises to take the initiative to strengthen communication in accordance with the principle of total difficulties and friendly consultations, and solve the difficulties and problems of small and medium-sized enterprises in accordance with the regulations in accordance with the regulations by postpone the performance and modify part of the contract terms, so as to maximize the help of enterprises to reduce losses or avoid losses. At the same time, we should explore joint countermeasures and plan long-term cooperation.